EFFECTS OF AN ORAL ANTIDIABETIC DRUG ON THE FIBRINOLYTIC SYSTEM OF BLOOD IN INSULIN-TREATED DIABETIC-PATIENTS

被引：27

作者：

GRAM, J

JESPERSEN, J

KOLD, A

机构：

[1] RIBE CTY HOSP ESBJERG,DEPT INTERNAL MED,DK-6700 ESBJERG,DENMARK

[2] S JUTLAND UNIV CTR,THROMBOSIS RES SECT,ESBJERG,DENMARK

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 1988年 / 37卷 / 10期

关键词：

D O I：

10.1016/0026-0495(88)90150-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：937 / 943

页数：7

共 34 条

[1] EFFECT OF CHLORPROPAMIDE AND GLICLAZIDE ON PLASMINOGEN-ACTIVATOR ACTIVITY IN VASCULAR WALLS IN PATIENTS WITH MATURITY ONSET DIABETES [J].

ALMER, LO .

THROMBOSIS RESEARCH, 1984, 35 (01) :19-25

[2]

ALMER LO, 1980, ACTA ENDOCR-COP S, V239, P53

[3] PLASMINOGEN PROACTIVATOR-ACTIVATOR SYSTEM IN HUMAN-BLOOD EFFECTIVE IN ABSENCE OF HAGEMAN-FACTOR [J].

ASTRUP, T ;

ROSA, AT .

THROMBOSIS RESEARCH, 1974, 4 (04) :609-613

[4]

BRAKMAN P, 1964, SANGRE, V9, P46

[5]

BROWNLEE M, 1983, DIABETES, V32, P600

[6]

CHAN TK, 1982, SEM HOP PARIS, V58, P1197

[7]

DESNOYERS P, 1980, ROY SOC MED, V20, P19

[8]

EPSTEIN SE, 1970, LANCET, V2, P631

[9]

FEARNLEY GR, 1959, LANCET, V2, P1067

[10] HEMOSTATIC VARIABLES ASSOCIATED WITH DIABETES AND ITS COMPLICATIONS [J].

FULLER, JH ;

KEEN, H ;

JARRETT, RJ ;

OMER, T ;

MEADE, TW ;

CHAKRABARTI, R ;

NORTH, WRS ;

STIRLING, Y .

BMJ-BRITISH MEDICAL JOURNAL, 1979, 2 (6196) :964-966

← 1 2 3 4 →